Voss Capital, LP
Source: SEC Form 13F · as of Mar 2026Voss Capital, LP holds 6 biotech & pharma companies tracked by BioSniper, totaling $26.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
6
Total value held
$26.3M
BioSniper AIPage evidence connected
Prepared research question
What matters most for uniQure N.V. (QURE)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| QUREuniQure N.V. | 605,000 | $9.9M |
| XERSXeris Biopharma Holdings, Inc. | 1,386,927 | $8.0M |
| RNTXRein Therapeutics, Inc. | 4,388,362 | $5.7M |
| RGNXREGENXBIO Inc. | 295,787 | $2.5M |
| CGTXCOGNITION THERAPEUTICS INC | 200,000 | $152K |
| LTRNLantern Pharma Inc. | 50,000 | $69K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.